Related Experiment Video
Updated: Apr 4, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
The influence of clopidogrel on ischemia diagnosed by myocardial perfusion stress testing
Ion S Jovin1,2, Keita A Ebisu3, Adriana D Oprea4
1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. isjovin@yahoo.com.
Insights
Clopidogrel does not appear to affect the diagnosis of myocardial ischemia during stress tests. This study found no evidence that clopidogrel use decreases the likelihood of detecting ischemia on myocardial perfusion scans.
Area of Science:
- Cardiology
- Nuclear Medicine
- Pharmacology
Background:
- Clopidogrel, a platelet adenosine receptor antagonist, may affect coronary vascular tone.
- This potential effect could interfere with myocardial perfusion imaging.
- The study aimed to determine if clopidogrel use impacts ischemia diagnosis in myocardial perfusion testing.
Purpose of the Study:
- To investigate the impact of clopidogrel on the diagnosis of myocardial ischemia.
- To assess whether clopidogrel use influences the detection of reversible perfusion defects in myocardial perfusion imaging.
Main Methods:
- Analysis of 6349 myocardial perfusion stress tests.
- Propensity analysis comparing patients on clopidogrel versus those not.
- Evaluation of reversible perfusion defects using single-photon emission computed tomography (SPECT) scans.
Main Results:
- The unadjusted odds ratio for reversible perfusion defects in clopidogrel users was 2.75 (P < .01).
- After propensity adjustment, the odds ratio was 1.06 for adenosine stress tests (P = .73) and 1.60 for exercise stress tests (P = .14).
- No statistically significant association was found between clopidogrel use and the presence of reversible perfusion defects after adjustment.
Conclusions:
- Clopidogrel use did not decrease the likelihood of ischemia detection.
- No evidence suggests clopidogrel hampers the diagnosis of ischemia in myocardial perfusion scans.
- The findings support the continued use of myocardial perfusion imaging in patients taking clopidogrel.
Background:
Clopidogrel is a platelet adenosine receptor antagonist which can influence coronary vascular tone and thus can potentially interfere with myocardial perfusion imaging. We investigated whether clopidogrel can hamper the diagnosis of ischemia in patients undergoing myocardial perfusion testing.
Methods:
Data from a database of 6349 myocardial perfusion stress tests were analyzed. Using a propensity analysis, patients who were taking clopidogrel were compared with patients not taking clopidogrel for the presence of reversible perfusion defects on myocardial single-photon emission computed tomography scans.
Results:
Of the 6349 tests, the stress technique was adenosine in 2713 patients and exercise in 3636. At the time of the stress test, 277 (4.3%) of the patients were taking clopidogrel. The odds ratio (OR) for patients taking clopidogrel to have a reversible perfusion defect was 2.75 (95% confidence interval [CI] 2.09-3.62; P < .01). After adjusting for the propensity to take clopidogrel, the OR was 1.06 (CI 0.76-1.49; P = .73) for patients undergoing adenosine stress tests and 1.60 (CI 0.85-3.00; P = .14) for patients undergoing exercise stress tests.
Conclusions:
We found no evidence that the use of clopidogrel decreases the likelihood of ischemia on adenosine or exercise stress myocardial perfusion scans.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System V: CT
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Acute Coronary Syndrome IV: Interprofessional Care

